Cellbyte is a company headquartered in Germany. Its most recent tracked round is Seed.
Cellbyte builds an enterprise AI platform that provides pricing, regulatory, HTA and market-access intelligence and agentic workflows to help pharmaceutical companies plan and execute global drug launches. Its product aggregates data from 100+ sources and offers document intelligence, benchmark analytics and human-in-the-loop AI agents for Pricing & Market Access teams.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.